Related Experiment Videos
Systemic amyloidosis: diagnosis before treatment.
Viviane M Conraads1, Cecile G Colpaert, Viviane Van Hoof
1Departments of Cardiology, University Hospital Antwerp, Belgium. viviane.conraads@uza.uia.ac.be
Summary
Familial amyloidotic polyneuropathy, a serious systemic disease, requires early diagnosis for effective liver transplantation. Misdiagnosis can lead to improper treatment, highlighting the need for clinical awareness.
Area of Science:
- Cardiology
- Neurology
- Genetics
Background:
- Familial amyloidotic polyneuropathy (FAP) is a rare, progressive systemic amyloidosis.
- Liver transplantation is a potential curative surgical treatment for FAP.
- Early diagnosis is crucial for patient prognosis and timely intervention.
Observation:
- A 49-year-old male patient presented with non-AA amyloidosis.
- Amyloid infiltration affected the heart and intestinal tract.
- Initial misidentification of the disease etiology resulted in inappropriate management.
Findings:
- The patient's condition was diagnosed as systemic amyloidosis.
- The specific type of amyloidosis was non-AA.
- The diagnostic delay and misidentification impacted treatment efficacy.
Implications:
- Increased awareness of FAP clinical features is vital for healthcare professionals.
- Prompt genetic diagnosis facilitates timely referral for liver transplantation.
- Accurate etiological identification prevents maltreatment and improves patient outcomes.